Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Alx Oncology Holdings (ALXO) Shares Outstanding (2019 - 2023)

Alx Oncology Holdings' Shares Outstanding history spans 5 years, with the latest figure at $41.2 million for Q3 2023.

  • For Q3 2023, Shares Outstanding rose 0.99% year-over-year to $41.2 million; the TTM value through Sep 2023 reached $41.2 million, up 0.99%, while the annual FY2022 figure was $40.9 million, 0.68% up from the prior year.
  • Shares Outstanding for Q3 2023 was $41.2 million at Alx Oncology Holdings, roughly flat from $41.0 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $41.2 million in Q3 2023 and bottomed at $3.2 million in Q2 2019.
  • The 5-year median for Shares Outstanding is $40.4 million (2021), against an average of $30.0 million.
  • The largest annual shift saw Shares Outstanding rose 0.16% in 2020 before it surged 1173.32% in 2021.
  • A 5-year view of Shares Outstanding shows it stood at $3.2 million in 2019, then skyrocketed by 1158.14% to $39.8 million in 2020, then rose by 1.86% to $40.6 million in 2021, then rose by 0.68% to $40.9 million in 2022, then increased by 0.71% to $41.2 million in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Shares Outstanding are $41.2 million (Q3 2023), $41.0 million (Q2 2023), and $40.9 million (Q1 2023).